Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use (MEASURE-ILD)

Development of an Intelligent Video Laryngoscope and Preliminary Verification for Emergency Application

The investigators are developing a video laryngoscope equipped with artificial intelligence technology to enable automatic identification of key airway anatomical structures and real-time guidance during intubation, with the aim of improving the success rate and efficiency of endotracheal intubation in emergency settings.

Studieöversikt

Studietyp

Interventionell

Inskrivning (Beräknad)

120

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • Zhejiang
      • Hangzhou, Zhejiang, Kina
        • Rekrytering
        • Second Affiliated Hospital, Zhejiang University, School of Medicine
        • Kontakt:
      • Shaoxing, Zhejiang, Kina, 312000

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Patient inclusion criteria: Adult patients in critical condition requiring endotracheal intubation via laryngoscopy (age ≥ 18 years).

Exclusion Criteria:

  • pregnant women, prisoners, recent history of airway surgery, oral or pharyngeal malformations, inability to perform randomization due to the need for emergency endotracheal intubation, or when the investigator deemed it necessary or contraindicated to use AIVL, VL, or DL during the first intubation attempt.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Video Laryngoscope(VL)

Participants randomized to this arm (n=60) will undergo the first endotracheal intubation attempt using a conventional video laryngoscope (VL), without AI-assisted anatomical identification or intubation guidance.

A conventional video laryngoscope will be used for the first endotracheal intubation attempt. The device displays the airway image without AI-assisted identification of anatomical structures or real-time AI intubation guidance.

Experimentell: AI-assisted Video Laryngoscope (AIVL)

Participants randomized to this arm (n=60) will undergo the first endotracheal intubation attempt using an AI-assisted video laryngoscope (AIVL), which provides real-time identification of airway anatomical structures and intubation guidance. Operators will receive standardized training on the device controls, guidance interface, and image display before use. Operators may decide whether to follow the AI guidance.

When using the AIVL for the first attempt at laryngoscopy intubation, the operator shall receive pre-procedural training, which primarily covers the functional buttons, the prompt interface, and image display.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
First-pass intubation success rate
Tidsram: The time from enrollment to completion of intubation (usually within 10 minutes).

Proportion of participants with successful endotracheal tube placement on the first laryngoscopic attempt, confirmed by end-tidal carbon dioxide monitoring.

The time from enrollment to completion of intubation (usually within 10 minutes).

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Intubation time
Tidsram: The time from enrollment to completion of intubation (usually within 10 minutes).

Time in seconds from insertion of the laryngoscope into the oral cavity until the endotracheal tube passes through the glottis.

The time from enrollment to completion of intubation (usually within 10 minutes).
Severe complications occurring within 2 minutes after intubation were defined as severe hypoxemia (peripheral SpO₂ <80%), severe hypotension (systolic blood pressure <65 mmHg), initiation of vasoactive agents, cardiac arrest, or death.
Tidsram: From enrollment to the 2 minutes after intubation
From enrollment to the 2 minutes after intubation
AI recall
Tidsram: The time from enrollment to completion of intubation (usually within 10 minutes).

True-positive anatomical detections divided by true-positive plus false-negative detections, assessed against reference annotations.

The time from enrollment to completion of intubation (usually within 10 minutes).
Duration of mechanical ventilation
Tidsram: From enrollment to the end of treatment at 8 weeks

Duration of mechanical ventilation, measured in days.

From enrollment to the end of treatment at 8 weeks
28-day all-cause mortality
Tidsram: From enrollment through day 28.

Proportion of participants who die from any cause within 28 days after enrollment.

From enrollment through day 28.
ICU length of stay
Tidsram: From enrollment through the end of treatment, up to 8 weeks.

Duration of intensive care unit stay, measured in days.

From enrollment through the end of treatment, up to 8 weeks.
Total hospital length of stay
Tidsram: From enrollment through the end of treatment, up to 8 weeks.

Total duration of hospitalization, measured in days.

From enrollment through the end of treatment, up to 8 weeks.
AI precision
Tidsram: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

True-positive anatomical detections divided by true-positive plus false-positive detections, assessed against reference annotations.

Video acquired from enrollment to completion of intubation, usually within 10 minutes.
AI specificity
Tidsram: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

True-negative assessments divided by true-negative plus false-positive assessments, assessed against reference annotations.

Video acquired from enrollment to completion of intubation, usually within 10 minutes.
AI F1 score
Tidsram: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

Harmonic mean of precision and recall: 2 x precision x recall / (precision + recall).

Video acquired from enrollment to completion of intubation, usually within 10 minutes.
Mean average precision (mAP)
Tidsram: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

Mean of average precision across the evaluated anatomical classes against reference annotations.

Video acquired from enrollment to completion of intubation, usually within 10 minutes.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 december 2026

Primärt slutförande (Beräknad)

31 december 2027

Avslutad studie (Beräknad)

31 december 2027

Studieregistreringsdatum

Först inskickad

22 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

1 november 2026

Första postat (Faktisk)

6 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

1 november 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera